ASBP
Aspire-Lakewood Holdings, Inc.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- R Jun 12 Aspire Biopharma ($8M market cap) signed a definitive agreement to a…
- E Jul 29 Trading halt: Halt Resumed: ASBP — trading resumed after LUDP (Volatilit…
- X Jul 31 Short interest falls 32.5% to 79.9K
- R Aug 10 Aspire Biopharma completed its acquisition of Dura Driver Control Sy…
- X Aug 31 Short interest falls 34.5% to 43.3K
- X Sep 30 Short interest falls 60.8% to 13.6K
- X Oct 15 Short interest falls 36.0% to 8.7K
- R Oct 20 Aspire-Lakewood Holdings, Inc. (ASBP) acquired Dura Driver Control S…
Signal stack
Where each data set points today.
- Short sellersCOVERING
Short interest −36.0% to 8.7K shares. 1.0 days to cover, ≈0.6% of shares.
- TrendRANGE
1% below its 50-day average.
Who's buying
13F| Top holder | Shares | Value |
|---|---|---|
| JANE STREET GROUP, LLC | 14,830 | $79.2K |
| GEODE CAPITAL MANAGEMENT, LLC | 10,474 | $55.9K |
| VANGUARD CAPITAL MANAGEMENT LLC | 10,408 | $55.6K |
| VANGUARD FIDUCIARY TRUST CO | 10,081 | $53.8K |
| TORONTO DOMINION BANK | 166 | $886.00 |
| UBS Group AG | 1 | $5.00 |
| BARCLAYS PLC | 1 | $5.00 |
Quarterly 13F filings are due 45 days after each quarter ends.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Oct 15, 2026| Jul 29, 2026 | Volatility Pause | Resumed |
SecBot reports
5 filings · 2 bullish · 0 bearish · 1 mixed · 2 neutral- MIXED 8-K/AOct 20, 2026
Aspire-Lakewood Holdings, Inc. (ASBP) acquired Dura Driver Control Systems (DCS) for approximately…
The acquisition fundamentally changes ASBP's business profile from a pre-revenue biopharma to an automotive supplier with ~$209M in revenue. Monitor integration execution, the final purchase price…
- NEUTRAL 8-KAug 19, 2026
Aspire Biopharma Holdings, Inc. filed an 8-K on August 19, 2026, solely to announce the…
This is a routine investor presentation distribution with no new financial information. Monitor for any subsequent filings that may contain material updates from the presentation content.
- BULLISH 8-KAug 10, 2026
Aspire Biopharma completed its acquisition of Dura Driver Control Systems (DCS) for approximately…
The acquisition fundamentally changes Aspire's revenue profile, but integration risk and debt service on the $22.5M facility are key watchpoints. Monitor upcoming quarterly filings for DCS's audited…
- NEUTRAL 8-KJul 20, 2026
Aspire Biopharma filed an 8-K to clarify the terms of its public warrants (ASBPW) following two…
This is a purely administrative clarification with no trading implications for ASBP common stock. The ASBPW warrants are now deeply out of the money with a $13,800 strike price, making them…
All ASBP filing & press-release reports (5)
- 8-K/A reportOct 20, 2026
- 8-K reportAug 19, 2026
- 8-K reportAug 10, 2026
- 8-K reportJul 20, 2026
- 8-K reportJun 12, 2026